Home/Filings/4/0000950170-23-034156
4//SEC Filing

Dworak Leiden 4

Accession 0000950170-23-034156

CIK 0001783328other

Filed

Jul 23, 8:00 PM ET

Accepted

Jul 24, 7:39 PM ET

Size

5.3 KB

Accession

0000950170-23-034156

Insider Transaction Report

Form 4
Period: 2023-07-21
Dworak Leiden
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-07-21+25,00025,000 total
    Exercise: $2.23Exp: 2033-07-20Voting Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of July 21, 2023, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.

Documents

1 file

Issuer

TScan Therapeutics, Inc.

CIK 0001783328

Entity typeother

Related Parties

1
  • filerCIK 0001986012

Filing Metadata

Form type
4
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 7:39 PM ET
Size
5.3 KB